Related Experiment Videos
Comments on evaluation of antisense drugs in the clinic
Antisense & Nucleic Acid Drug Development
|July 25, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The concept and application of antisense oligonucleotides.
Diseases of the colon and rectum·2001
Hepatic distribution of a phosphorothioate oligodeoxynucleotide within rodents following intravenous administration.
Biochemical pharmacology·2001
Investigating the structure of human RNase H1 by site-directed mutagenesis.
The Journal of biological chemistry·2001
Variations in mRNA content have no effect on the potency of antisense oligonucleotides.
Antisense & nucleic acid drug development·2001
Human RNase III is a 160-kDa protein involved in preribosomal RNA processing.
The Journal of biological chemistry·2000
Progress in the delivery of therapeutic oligonucleotides: organ/cellular distribution and targeted delivery of oligonucleotides in vivo.
Antisense & nucleic acid drug development·2003
Safety of CpG oligodeoxynucleotides in veterinary species.
Antisense & nucleic acid drug development·2003
Coupling of RNAi-mediated target downregulation with gene replacement.
Antisense & nucleic acid drug development·2003
Inhibitory oligonucleotides block the induction of AP-1 transcription factor by stimulatory CpG oligonucleotides in B cells.
Antisense & nucleic acid drug development·2003
Evaluation of C-5 propynyl pyrimidine-containing oligonucleotides in vitro and in vivo.
Antisense & nucleic acid drug development·2003
Effects of base modifications on antisense properties of 2'-O-methoxyethyl and PNA oligonucleotides.
Antisense & nucleic acid drug development·2003
Regulatory roles of pyroptosis-associated lncRnas in breast cancer progression and immune microenvironment.
Cell cycle (Georgetown, Tex.)·2026
Insights Into the Mechanisms of Biological Aging That Guide Translational and Clinical Research.
Aging medicine (Milton (N.S.W))·2026
Depletion of Soluble PD-L1 with Engineered Nanoparticles Promotes Antitumor Immunity and Tumor Control.
International journal of nanomedicine·2026
Biomaterial-based Drug delivery strategies for head and neck cancer: Local delivery, combination therapy, and translational challenges.
International journal of pharmaceutics: X·2026
Enhanced anticancer efficacy of Pa-MAP 1.9 peptide-coated silver nanostars on breast cancer cells.
Materials today. Bio·2026